This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PDL BioPharma Inc (PDLI)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 3.29
52 Week High 6.83
52 Week Low 2.58
Avg. Daily Vol. (Mil) 2.31
Beta (3 year) 0.81
Share Related Items
Mkt Cap (Mil) 543.23
Shares Out (Mil) 164.29
Float (Mil) 144.96
Dividend Information
Yield % 6.10
Annual Dividend 0.20
Payout Ratio 30.00
Financial Strength
Quick Ratio 7.60
Current Ratio 7.70
LT Debt/ Equity 0.33
Total Debt / Equity 0.37
Valuation Ratios
Price Earnings 1.60
Price/Sales 0.98
Price/Book 0.78
Price/Cash Flow 1.60
Per Share Data
Earnings 2.03
Sales 3.37
Book Value 4.24
Cash Flow 2.10
Business Summary
PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer & immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets & maximizing value of its patent.
General Information
932 Southwood Boulevard
Incline Villiage, NV 89451
Industry : Drugs
Sector: Health Care
Employees: 10
CEO: Mr. John P. Mclaughlin
Short Interest
Current Month (Mil) 13.27
Previous Month (Mil) 13.41
Short Interest Ratio (Days) 5.80
Management Effectiveness
Return on Equity 47.80
Return on Assets 32.70
Return on Investments 35.80
Gross Margin n.a.
EBIT Margin 98.20
Profit Margin 60.00

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PDLI PDL BioPharma Inc

Chart of PDLI

Analysts Ratings for PDLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

PDLI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs